IMPROVE 2023: The 2nd International Meeting on Pathway‐Related Obesity: Vision & Evidence
ABSTRACT A total of 150 clinicians and researchers representing 19 countries came together in person and online to participate in the highly anticipated 2nd International Meeting on Pathway‐Related Obesity: Vision & Evidence (IMPROVE), held on 13–15 December 2023 in Paris, France.
Karine Clément+19 more
wiley +1 more source
The Role of Adipokines and Gene Polymorphisms in the Development of Obesity- Induced Depression. [PDF]
Ercan SN, Sanlier N.
europepmc +1 more source
Is Leptin Concentration Associated with the Insulin Resistance Syndrome in Nondiabetic Men?
Steven M. Haffner+4 more
openalex +1 more source
ABSTRACT Obesity appears to be associated with improved health outcomes in patients with sepsis, a phenomenon termed the obesity paradox. However, the potential influence of varying operational definitions of obesity on clinical outcomes within this paradox remains inadequately characterised.
Efris Kartikasari+2 more
wiley +1 more source
Influence of Maternal Glycemia on Breast Milk Composition and Volume Ingested by Infants of Mothers With Type 1 Diabetes. [PDF]
Donovan LE+8 more
europepmc +1 more source
Regulation of Neuronal and Glial Proteins by Leptin: Implications for Brain Development* [PDF]
Rexford S. Ahima+3 more
openalex +1 more source
Association of Leptin in Sarcopenia and Bone Density in Elderly Women: An Observational Analysis. [PDF]
Lee DG, Lee JH.
europepmc +1 more source
Differential Effects of Leptin in Regulation of Tissue Glucose Utilization in Vivo
J.-l. Wang
openalex +1 more source
Short Term Effects of Leptin on Hepatic Gluconeogenesis and in Vivo Insulin Action [PDF]
Luciano Rossetti+7 more
openalex +1 more source
Neurobeachin (NBEA) is a novel gene associated with GLP‐1 receptor agonist associated weight loss
Abstract Aims Nearly 42% of adults in the United States have obesity, a significant risk factor for many cardiometabolic diseases and cancers. Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are promising interventions for weight loss, but their efficacy varies significantly across individuals.
Arshiya Mariam‐Smith+6 more
wiley +1 more source